Please use this identifier to cite or link to this item: http://hdl.handle.net/10790/3450

Cost-Effectiveness of Phenytoin and Levetiracetam for Seizure Prophylaxis in Traumatic Brain Injury

File SizeFormat 
Young NCS Poster.pdf898.89 kBAdobe PDFView/Open

Item Summary

Title: Cost-Effectiveness of Phenytoin and Levetiracetam for Seizure Prophylaxis in Traumatic Brain Injury
Authors: Young, Nicole
Tokumaru, Sheri
Taira, Deborah
Izumi, Kara
Stern, Tracy
show 3 moreDittrich, Denise
Asai, Susan
Nakagawa, Kazuma

show less
Instructor: Tokumaru, Sheri
Taira, Deborah
Keywords: Traumatic brain injury
Anticonvulsants
Seizure prophylaxis
Phenytoin
Levetiracetam
show 1 moreCost effectiveness
show less
Issue Date: 06 Apr 2018
Abstract: Seizures are a potential complication associated with traumatic brain injury (TBI), which can lead to secondary brain injury and increased risk for developing post-traumatic epilepsy. Current guidelines recommend the use of antiepileptic drug (AED) for early seizure prophylaxis in patients with TBI. Both phenytoin (PHE) and levetiracetam (LEV) have become standard of practice for seizure prophylaxis in TBI, yet the cost effectiveness is not well studied.
Description: Poster
Sponsor: The Queen's Medical Center, John A. Burns School of Medicine
Pages/Duration: 1 poster
URI/DOI: http://hdl.handle.net/10790/3450
Rights: Open access
Appears in Collections:DKICP Resident Posters



Please email libraryada-l@lists.hawaii.edu if you need this content in an ADA-compliant format.

This item is licensed under a Creative Commons License Creative Commons